Drug intelligence / Profile preview

regadenoson + optison

Development stage
Unknown
Lead developer
GE Healthcare
Modality
Small Molecules
Administration
Intravenous
01

Overview

Regadenoson + Optison is a combination used in cardiac imaging procedures, particularly for myocardial perfusion and echocardiography. Regadenoson is a selective adenosine A2A receptor agonist that induces coronary vasodilation, increasing blood flow to the heart and helping identify areas of reduced perfusion due to coronary artery disease. Optison (perflutren protein-type A microspheres) is an ultrasound contrast agent that enhances the visualization of cardiac structures during echocardiography by opacifying the left ventricle and improving delineation of endocardial borders. This combination may be used in stress echocardiography protocols where regadenoson acts as a pharmacologic stress agent and Optison improves image quality[1][2][3][5][8].

Brand names
Lexiscan
Other names
perflutren protein-type A microspheresperflutren microspheres
02

Targets

ADORA2A (Adenosine A₂A Receptor)

Beyond the preview

Go deeper on regadenoson + optison.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on regadenoson + optison.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call